Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy.

Ismahil MA, Hamid T, Haberzettl P, Gu Y, Chandrasekar B, Srivastava S, Bhatnagar A, Prabhu SD.

Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2050-60. doi: 10.1152/ajpheart.00120.2011. Epub 2011 Sep 9.

2.

Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure.

Luo J, Hill BG, Gu Y, Cai J, Srivastava S, Bhatnagar A, Prabhu SD.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3673-84. Epub 2007 Oct 5.

3.

α,β-Unsaturated aldehyde pollutant acrolein suppresses cardiomyocyte contractile function: Role of TRPV1 and oxidative stress.

Wu Z, He EY, Scott GI, Ren J.

Environ Toxicol. 2015 May-Jun;30(6):638-47. doi: 10.1002/tox.21941. Epub 2013 Dec 23.

PMID:
24376112
4.

A dilated cardiomyopathy mutation blunts adrenergic response and induces contractile dysfunction under chronic angiotensin II stress.

Wilkinson R, Song W, Smoktunowicz N, Marston S.

Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1936-46. doi: 10.1152/ajpheart.00327.2015. Epub 2015 Oct 2.

5.

Ectopic trypsin in the myocardium promotes dilated cardiomyopathy after influenza A virus infection.

Pan HY, Sun HM, Xue LJ, Pan M, Wang YP, Kido H, Zhu JH.

Am J Physiol Heart Circ Physiol. 2014 Sep 15;307(6):H922-32. doi: 10.1152/ajpheart.00076.2014. Epub 2014 Jul 18.

6.

Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.

Osadchii OE, Norton GR, McKechnie R, Deftereos D, Woodiwiss AJ.

Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1898-905. Epub 2006 Dec 8.

7.

Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.

Westermann D, Becher PM, Lindner D, Savvatis K, Xia Y, Fröhlich M, Hoffmann S, Schultheiss HP, Tschöpe C.

Basic Res Cardiol. 2012 Nov;107(6):308. doi: 10.1007/s00395-012-0308-y. Epub 2012 Nov 2. Erratum in: Basic Res Cardiol. 2013 Mar;108(2):327.

PMID:
23117837
8.

Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.

Wang AW, Song L, Miao J, Wang HX, Tian C, Jiang X, Han QY, Yu L, Liu Y, Du J, Xia YL, Li HH.

Am J Hypertens. 2015 Apr;28(4):518-26. doi: 10.1093/ajh/hpu194. Epub 2014 Oct 31.

PMID:
25362112
9.

Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H587-96. doi: 10.1152/ajpheart.00298.2012. Epub 2012 Jun 22.

10.

Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.

Ishimaru K, Miyagawa S, Fukushima S, Saito A, Sakai Y, Ueno T, Sawa Y.

J Thorac Cardiovasc Surg. 2013 Dec;146(6):1516-25. doi: 10.1016/j.jtcvs.2013.02.045.

11.

Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis.

Cheung CT, Deisher TA, Luo H, Yanagawa B, Bonigut S, Samra A, Zhao H, Walker EK, McManus BM.

Lab Invest. 2007 Jul;87(7):651-61. Epub 2007 Apr 30.

12.

Role of endoplasmic reticulum stress in acrolein-induced endothelial activation.

Haberzettl P, Vladykovskaya E, Srivastava S, Bhatnagar A.

Toxicol Appl Pharmacol. 2009 Jan 1;234(1):14-24. doi: 10.1016/j.taap.2008.09.019. Epub 2008 Oct 7.

13.

Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection.

Wang GW, Guo Y, Vondriska TM, Zhang J, Zhang S, Tsai LL, Zong NC, Bolli R, Bhatnagar A, Prabhu SD.

J Mol Cell Cardiol. 2008 Jun;44(6):1016-22. doi: 10.1016/j.yjmcc.2008.03.020. Epub 2008 Apr 8.

PMID:
18468618
14.

Alterations of gene expression in failing myocardium following left ventricular assist device support.

Chen Y, Park S, Li Y, Missov E, Hou M, Han X, Hall JL, Miller LW, Bache RJ.

Physiol Genomics. 2003 Aug 15;14(3):251-60.

PMID:
12824457
15.

Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.

Ellmers LJ, Scott NJ, Cameron VA, Richards AM, Rademaker MT.

J Cardiovasc Pharmacol. 2015 Mar;65(3):269-75. doi: 10.1097/FJC.0000000000000190.

PMID:
25658462
16.

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.

Shiomi T, Tsutsui H, Hayashidani S, Suematsu N, Ikeuchi M, Wen J, Ishibashi M, Kubota T, Egashira K, Takeshita A.

Circulation. 2002 Dec 10;106(24):3126-32.

17.

Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.

Muranaka H, Marui A, Tsukashita M, Wang J, Nakano J, Ikeda T, Sakata R.

J Thorac Cardiovasc Surg. 2010 Oct;140(4):916-22. doi: 10.1016/j.jtcvs.2010.02.006. Epub 2010 Apr 9.

18.
19.

Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.

Quattrocelli M, Crippa S, Montecchiani C, Camps J, Cornaglia AI, Boldrin L, Morgan J, Calligaro A, Casasco A, Orlacchio A, Gijsbers R, D'Hooge J, Toelen J, Janssens S, Sampaolesi M.

J Am Heart Assoc. 2013 Aug 20;2(4):e000284. doi: 10.1161/JAHA.113.000284.

20.

A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.

Shirasaka T, Miyagawa S, Fukushima S, Saito A, Shiozaki M, Kawaguchi N, Matsuura N, Nakatani S, Sakai Y, Daimon T, Okita Y, Sawa Y.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):413-21. doi: 10.1016/j.jtcvs.2012.10.003. Epub 2013 Mar 28.

Supplemental Content

Support Center